{"id":"https://openalex.org/W2801438121","doi":"https://doi.org/10.1093/jac/dky132","title":"Insights about minority HIV-1 strains in transmitted drug resistance mutation dynamics and disease progression","display_name":"Insights about minority HIV-1 strains in transmitted drug resistance mutation dynamics and disease progression","alternate_titles":[],"publication_year":2018,"publication_date":"2018-04-17","ids":{"openalex":"https://openalex.org/W2801438121","doi":"https://doi.org/10.1093/jac/dky132","mag":"2801438121","pmid":"https://pubmed.ncbi.nlm.nih.gov/29684141"},"language":"en","primary_location":{"id":"doi:10.1093/jac/dky132","doi":"https://doi.org/10.1093/jac/dky132","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dky132","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2801438121"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013569572","display_name":"Ana Rachel L\u00e9da","orcid":"https://orcid.org/0000-0003-0276-0487","observed_orcids":["https://orcid.org/0000-0003-0276-0487"]},"institutions":[{"id":"https://openalex.org/I88273585","display_name":"Universidade Federal de S\u00e3o Paulo","ror":"https://ror.org/02k5swt12","country_code":"BR","type":"education","lineage":["https://openalex.org/I88273585"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Ana Rachel Leda","raw_affiliation_strings":["Infectious Diseases Division, Department of Medicine, Federal University of Sao Paulo, Sao Paulo - SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Division, Department of Medicine, Federal University of Sao Paulo, Sao Paulo - SP, Brazil","institution_ids":["https://openalex.org/I88273585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003518755","display_name":"James Hunter","orcid":"https://orcid.org/0000-0001-9524-0629","observed_orcids":["https://orcid.org/0000-0001-9524-0629"]},"institutions":[{"id":"https://openalex.org/I88273585","display_name":"Universidade Federal de S\u00e3o Paulo","ror":"https://ror.org/02k5swt12","country_code":"BR","type":"education","lineage":["https://openalex.org/I88273585"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"James Hunter","raw_affiliation_strings":["Infectious Diseases Division, Department of Medicine, Federal University of Sao Paulo, Sao Paulo - SP, Brazil"],"raw_orcid":"https://orcid.org/0000-0001-9524-0629","affiliations":[{"raw_affiliation_string":"Infectious Diseases Division, Department of Medicine, Federal University of Sao Paulo, Sao Paulo - SP, Brazil","institution_ids":["https://openalex.org/I88273585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016375171","display_name":"\u00darsula Castro de Oliveira","orcid":"https://orcid.org/0000-0002-4811-757X","observed_orcids":["https://orcid.org/0000-0002-4811-757X"]},"institutions":[{"id":"https://openalex.org/I2800423888","display_name":"Instituto Butantan","ror":"https://ror.org/01whwkf30","country_code":"BR","type":"facility","lineage":["https://openalex.org/I2800423888"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Ursula Castro Oliveira","raw_affiliation_strings":["Butantan Institute, Sao Paulo - SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Butantan Institute, Sao Paulo - SP, Brazil","institution_ids":["https://openalex.org/I2800423888"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036009540","display_name":"In\u00e1cio L.M. Junqueira-de-Azevedo","orcid":"https://orcid.org/0000-0003-4491-0180","observed_orcids":["https://orcid.org/0000-0003-4491-0180"]},"institutions":[{"id":"https://openalex.org/I2800423888","display_name":"Instituto Butantan","ror":"https://ror.org/01whwkf30","country_code":"BR","type":"facility","lineage":["https://openalex.org/I2800423888"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Inacio Junqueira Azevedo","raw_affiliation_strings":["Butantan Institute, Sao Paulo - SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Butantan Institute, Sao Paulo - SP, Brazil","institution_ids":["https://openalex.org/I2800423888"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065077331","display_name":"Maria Cec\u00edlia Araripe Sucupira","orcid":"https://orcid.org/0000-0002-1114-5382","observed_orcids":["https://orcid.org/0000-0002-1114-5382"]},"institutions":[{"id":"https://openalex.org/I88273585","display_name":"Universidade Federal de S\u00e3o Paulo","ror":"https://ror.org/02k5swt12","country_code":"BR","type":"education","lineage":["https://openalex.org/I88273585"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Maria Cecilia Araripe Sucupira","raw_affiliation_strings":["Infectious Diseases Division, Department of Medicine, Federal University of Sao Paulo, Sao Paulo - SP, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Diseases Division, Department of Medicine, Federal University of Sao Paulo, Sao Paulo - SP, Brazil","institution_ids":["https://openalex.org/I88273585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079615499","display_name":"Ricardo Sobhie Diaz","orcid":"https://orcid.org/0000-0002-8395-7304","observed_orcids":["https://orcid.org/0000-0002-8395-7304","https://orcid.org/0000-0002-5889-2836"]},"institutions":[{"id":"https://openalex.org/I88273585","display_name":"Universidade Federal de S\u00e3o Paulo","ror":"https://ror.org/02k5swt12","country_code":"BR","type":"education","lineage":["https://openalex.org/I88273585"]}],"countries":["BR"],"is_corresponding":true,"raw_author_name":"Ricardo Sobhie Diaz","raw_affiliation_strings":["Infectious Diseases Division, Department of Medicine, Federal University of Sao Paulo, Sao Paulo - SP, Brazil"],"raw_orcid":"https://orcid.org/0000-0002-8395-7304","affiliations":[{"raw_affiliation_string":"Infectious Diseases Division, Department of Medicine, Federal University of Sao Paulo, Sao Paulo - SP, Brazil","institution_ids":["https://openalex.org/I88273585"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5079615499"],"corresponding_institution_ids":["https://openalex.org/I88273585"],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":0.7432,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.67921772,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"73","issue":"7","first_page":"1930","last_page":"1934"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9473000168800354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9473000168800354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.04520000144839287,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.8069999814033508},{"id":"https://openalex.org/keywords/ultra-deep-sequencing","display_name":"ultra-deep sequencing","score":0.7889999747276306},{"id":"https://openalex.org/keywords/viral-load","display_name":"viral load","score":0.6269999742507935},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.875},{"id":"https://openalex.org/keywords/reverse-transcriptase","display_name":"reverse transcriptase","score":0.7419999837875366},{"id":"https://openalex.org/keywords/hiv-protease","display_name":"HIV protease","score":0.7720000147819519},{"id":"https://openalex.org/keywords/antiretroviral-drug-resistance","display_name":"antiretroviral resistance","score":0.7390000224113464},{"id":"https://openalex.org/keywords/seroconversion","display_name":"seroconversion","score":0.6349999904632568},{"id":"https://openalex.org/keywords/viral-persistence","display_name":"viral persistence","score":0.41499999165534973}],"concepts":[{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.7622709274291992},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.7481472492218018},{"id":"https://openalex.org/C132917006","wikidata":"https://www.wikidata.org/wiki/Q5250436","display_name":"Deep sequencing","level":4,"score":0.6892392039299011},{"id":"https://openalex.org/C2777451964","wikidata":"https://www.wikidata.org/wiki/Q2141450","display_name":"Seroconversion","level":3,"score":0.6587007641792297},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6237468719482422},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.6155625581741333},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.6066418290138245},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.563409149646759},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.4905056357383728},{"id":"https://openalex.org/C182707283","wikidata":"https://www.wikidata.org/wiki/Q7315622","display_name":"Resistance mutation","level":5,"score":0.45929282903671265},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.4070960581302643},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.2865709364414215},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.24181202054023743},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2358005940914154},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23279541730880737},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1640925407409668},{"id":"https://openalex.org/C141231307","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genome","level":3,"score":0.0945267379283905},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001938","descriptor_name":"Brazil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006679","descriptor_name":"HIV Seropositivity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011533","descriptor_name":"Proviruses","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D059014","descriptor_name":"High-Throughput Nucleotide Sequencing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/jac/dky132","doi":"https://doi.org/10.1093/jac/dky132","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dky132","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:29684141","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29684141","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G4372517233","display_name":"HIV quasispecies studies using ultra-deep sequencing","funder_award_id":"11/12156-0","funder_id":"https://openalex.org/F4320320997","funder_display_name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo"},{"id":"https://openalex.org/G4492565863","display_name":null,"funder_award_id":"2011/50238\u20138","funder_id":"https://openalex.org/F4320320997","funder_display_name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo"}],"funders":[{"id":"https://openalex.org/F4320320997","display_name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","ror":"https://ror.org/02ddkpn78"},{"id":"https://openalex.org/F4320338304","display_name":"Los Alamos National Laboratory","ror":"https://ror.org/01e41cf67"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W65942279","https://openalex.org/W1977799995","https://openalex.org/W1978200981","https://openalex.org/W1994877856","https://openalex.org/W2002574877","https://openalex.org/W2016664919","https://openalex.org/W2024585092","https://openalex.org/W2025935798","https://openalex.org/W2029424399","https://openalex.org/W2035148156","https://openalex.org/W2049274376","https://openalex.org/W2066695070","https://openalex.org/W2089357082","https://openalex.org/W2097030610","https://openalex.org/W2115919618","https://openalex.org/W2126141460","https://openalex.org/W2132938931","https://openalex.org/W2148476904","https://openalex.org/W2160412419","https://openalex.org/W2161221967","https://openalex.org/W2165346130","https://openalex.org/W2167426110","https://openalex.org/W2327477206","https://openalex.org/W6602700112","https://openalex.org/W6683655917"],"related_works":["https://openalex.org/W2890824032","https://openalex.org/W1479770025","https://openalex.org/W2758446463","https://openalex.org/W2912386081","https://openalex.org/W1965838009","https://openalex.org/W2102093869","https://openalex.org/W1997715838","https://openalex.org/W6901639967","https://openalex.org/W1966063036","https://openalex.org/W2904790229"],"abstract_inverted_index":{"Objectives:":[0],"The":[1,132],"presence":[2,133],"of":[3,38,56,63,78,134,161],"minority":[4],"transmitted":[5,69,135],"drug":[6,70,120,136,155],"resistance":[7,71,121,137,156],"mutations":[8,72,92,138,157],"was":[9,139],"assessed":[10],"using":[11],"ultra-deep":[12,54],"sequencing":[13,55,96,116],"and":[14,32,45,60,105,146],"correlated":[15,141],"with":[16,99,108,123,142,147],"disease":[17],"progression":[18],"among":[19],"recently":[20],"HIV-1-infected":[21],"individuals":[22,50],"from":[23,48,88],"Brazil.":[24],"Methods:":[25],"Samples":[26],"at":[27],"baseline":[28],"during":[29,168],"recent":[30],"infection":[31,40,169],"1":[33],"year":[34,178],"after":[35,179],"the":[36,39,57,79,143,162,176],"establishment":[37],"were":[41,51,73,111],"analysed.":[42],"Viral":[43,66],"RNA":[44],"proviral":[46],"DNA":[47],"25":[49,80],"subjected":[52],"to":[53,90],"reverse":[58],"transcriptase":[59],"protease":[61],"regions":[62],"HIV-1.":[64],"Results:":[65],"strains":[67,98,107,122],"carrying":[68],"detected":[74,97,112],"in":[75,175],"9":[76],"out":[77],"patients,":[81],"for":[82],"all":[83],"major":[84],"antiretroviral":[85],"classes,":[86],"ranging":[87],"one":[89],"five":[91],"per":[93],"patient.":[94],"Ultra-deep":[95],"frequencies":[100,109,124],"as":[101,103],"low":[102],"1.6%":[104],"only":[106],">20%":[110],"by":[113],"population":[114,164],"plasma":[115],"(three":[117],"patients).":[118],"Transmitted":[119,154],"<14.8%":[125],"did":[126],"not":[127,166],"persist":[128,167],"upon":[129],"established":[130],"infection.":[131],"negatively":[140,173],"viral":[144,163],"load":[145],"CD4+":[148],"T":[149],"cell":[150],"count":[151],"decay.":[152],"Conclusions:":[153],"representing":[158],"small":[159],"percentages":[160],"do":[165],"because":[170],"they":[171],"are":[172],"selected":[174],"first":[177],"HIV-1":[180],"seroconversion.":[181]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2801438121","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2018-05-17T00:00:00"}
